Corporate snippets
² Bharti Airtel is set to extend its 4G footprint to 19 circles in next 3-4 months as it will be launching services in six circles where it acquired spectrum from Videocon Telecommunications. (BS)
² Cipla is investing 1.3bn South African Rand (about Rs6bn) in a biotech plant in South Africa as it aims to make cancer drugs affordable and grow its presence in the market. (BS)
² DLF has shortlisted six potential buyers for 40% stake of the promoters in its rental arm DLF Cyber City Developers that is expected to sell for about Rs 130bn. (ET)
² Cadila Healthcare has received Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility in Moraiya. (BL)
² Scepticism over the Rs48bn acquisition of Reliance Cement shrouded Birla Corporation's annual general meeting as shareholders raised questions about the feasibility of the deal as well as its financing. (BL)
² Lupin said US health regulator has voiced minor concerns after completing the inspection of its Dabhasa facility in Gujarat.(ET)
² Cadila Healthcare sees big growth opportunity in US and Latin American formulation markets and plans to enhance share in the US generics market by launching complex, oral solids and formulations.
² Telecom Ministry is learnt to have cleared the Rs35bn 4G spectrum trading deal between service providers Bharti Airtel and Aircel. (BS)
² Dishman Pharmaceuticals and Chemicals Ltd has completely moved away from Vitamin D3 production and has instead entered a high-margin, low volume category of analogs and cholesterol. (BS)
² The Odisha Pollution Control Board has extended the validity of the consent to establish order issued to DLF by five years. (BS)
You received this message because you are subscribed to the Google Groups "LONGTERMINVESTORSRESEARCH" group.
To unsubscribe from this group and stop receiving emails from it, send an email to longterminvestorsresearch+unsubscribe@googlegroups.com.
Visit this group at https://groups.google.com/group/longterminvestorsresearch.
For more options, visit https://groups.google.com/d/optout.
No comments:
Post a Comment